Akers Biosciences Inc. (AKER): Price and Financial Metrics
AKER Price/Volume Stats
| Current price | $4.94 | 52-week high | $6.97 |
| Prev. close | $2.73 | 52-week low | $1.65 |
| Day low | $4.81 | Volume | 791,750 |
| Day high | $6.08 | Avg. volume | 769,876 |
| 50-day MA | $3.32 | Dividend yield | N/A |
| 200-day MA | $3.03 | Market Cap | 82.27M |
AKER Stock Price Chart Interactive Chart >
Akers Biosciences Inc. (AKER) Company Bio
Akers Biosciences, Inc. focuses on the development of a vaccine candidate against SARS-CoV-2, a coronavirus causing a pandemic. It has a collaboration agreement with Premas Biotech PVT Ltd. The company was founded in 1989 and is headquartered in Thorofare, New Jersey.
AKER Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | -64.63% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | 0.00% |
| 2020 | -37.81% |
| 2019 | -88.20% |
Continue Researching AKER
Want to see what other sources are saying about Akers Biosciences Inc's financials and stock price? Try the links below:Akers Biosciences Inc (AKER) Stock Price | Nasdaq
Akers Biosciences Inc (AKER) Stock Quote, History and News - Yahoo Finance
Akers Biosciences Inc (AKER) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...